<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01283646</url>
  </required_header>
  <id_info>
    <org_study_id>TRPEMS0910</org_study_id>
    <nct_id>NCT01283646</nct_id>
  </id_info>
  <brief_title>Efficacy and Tolerability of Apevitin BC Comparing to Vitamin Complex in Stimulating the Appetite</brief_title>
  <acronym>Inappetence</acronym>
  <official_title>Multicenter Clinical Study, Phase III, Randomized, Double-blind, of Prospectively Evaluate the Effectiveness and Tolerability of Apevitin BC Comparing to Vitamin Complex in Appetite Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EMS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EMS</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lack of appetite is one of the most common reasons for visits to pediatric clinics.The
      symptoms usually manifest after weaning when they are introduced into the diet of infant
      foods containing salt.Is normally used to cyproheptadine in conjunction with vitamins C and B
      and also vitamins complex.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design:

        -  Multicenter

        -  Phase III

        -  Randomized

        -  Double Blind

        -  Prospective and Comparative

        -  Experiment duration: 30 days

        -  3 visits (day 0, day 15 and day 30)

        -  Increased appetite

        -  Adverse event
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the effectiveness of Apevitin BC in appetite stimulation compared to vitamin complex.</measure>
    <time_frame>30 days</time_frame>
    <description>Clinical evaluation of the patient's general condition. The lowest responsible will report less data about their inappetence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the tolerability of Apevitin BC in stimulating the appetite compared to vitamin complex</measure>
    <time_frame>30 days</time_frame>
    <description>The lowest responsible will repost less data about their inappetence.Final evaluation of efficacy and tolerability.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Lack or Loss Appetite Nonorganic Origin</condition>
  <arm_group>
    <arm_group_label>Apevitin BC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children (5 to 6 years): 3.5 ml 3 times a daily Children (7 to 15 years): 5 ml 3 times a daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin B Complex + Vitamin C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children (5 to 6 years): 3.5 ml 3 times a daily Children (7 to 15 years): 5 ml 3 times a daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Apevitin BC</intervention_name>
    <description>3.5 to 5 ml 3 times a daily</description>
    <arm_group_label>Apevitin BC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin B Complex + Vitamin C</intervention_name>
    <description>3.5 to 5 ml 3 times a daily</description>
    <arm_group_label>Vitamin B Complex + Vitamin C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with inappetence;

          -  Wash out 20 days after ingestion before similar drug;

          -  The charge of the patient must understand and consent in writing;

          -  Responsible for the minor must be able to understand the study procedures, agree to
             participate and give written consent.

        Exclusion Criteria:

          -  Patients with intestinal parasitoses infection;

          -  Patients with glaucoma open or closure angle;

          -  Patients with predisposition to urinary retention;

          -  Patients with stenosis peptic ulcer or pylorus - duodenal obstruction;

          -  Debilitated patients or in acute attack of asthma;

          -  Patients who have lass of appetite caused by any serious disease;

          -  Patients who make use of any drugs central nervous system depressants;

          -  Patients who make use of medicines monoamineoxidase inhibitors, tricyclic
             antidepressants, phenothiazines, probenecid, levodopa, phenytoin, Phenobarbital,
             chloramphenicol, cyclosphosphamide, cyclosporine, chlorambucil,corticotropin,
             mercaptopurine, isoniazid , penicillin, estrogens, contraceptives, haloperidol,
             ipratropium, barbiturates, primidone, salicylates.

          -  Hypersensitivity to components of the formula

          -  Patients who is participating in another clinical study;

          -  No able to adhere to protocol;

          -  Any pathology or past medical condition that can interfere with this protocol.

          -  Other conditions deemed reasonable by the medical investigator as to the
             disqualification of the individual from study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felipe Pinho, MD</last_name>
    <role>Study Director</role>
    <affiliation>EMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculdade de Medicina do ABC</name>
      <address>
        <city>Santo André</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica A/Z</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica Dr. Felício Savioli</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2011</study_first_submitted>
  <study_first_submitted_qc>January 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2011</study_first_posted>
  <last_update_submitted>March 1, 2013</last_update_submitted>
  <last_update_submitted_qc>March 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

